Skip to main content

SCYNEXIS Inc. Common Stock (SCYX)

About The Company

SCYX Stock Market Logo

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address significant unmet therapeutic needs. It is engaged in developing a lead product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against a broad range of Candida and Aspergillus species, including drug-resistant strains.

IPO Year Sector Industry
2014 Health Care Biotechnology: Pharmaceutical Preparations

SCYNEXIS Inc. (SCYX) Latest News

Company Contact & Address (SCYX)

Corporate Headquarters Phone Website
New Jersey,
07302 – 6548,
United States
+1 201 884-5485 Official SCYX Website

SCYX Key Executives

Ownership and management information.

Key Data Points*

Exchange Not Available Market Cap Not Available
Sector Health Care P/E Ratio Not Available
Industry Biotechnology: Pharmaceutical Preparations Forward P/E 1 Yr. Not Available
1 Year Target Not Available Earnings Per Share (EPS) Not Available
Today’s High/Low Not Available Annualized Dividend Not Available
Share Volume Not Available Ex Dividend Date Not Available
Average Volume Not Available Dividend Pay Date Not Available
Previous Close Not Available Current Yield Not Available
52 Week High/Low Not Available Beta Not Available

* Information and data may delayed

Officers & Directors @ SCYX

Jobs & Employment at SCYNEXIS Inc.

LinkedIn Company Page
Official Career & Employment Page Employment & Careers at SCYNEXIS Inc. (SCYX)

Related & Similar Stock Symbols

OMC Stock Market Price & News


Omnicom Group Inc. Common Stock

NEE^O Stock Market Price & News


NextEra Energy Inc. 4.872% Corporate Units

OTEC Stock Market Price & News


OceanTech Acquisitions I Corp. Class A Common …